Detalhe da pesquisa
1.
Rationale and design of the PROMETCO study: a real-world, prospective, longitudinal cohort on the continuum of care of metastatic colorectal cancer from a clinical and patient perspective.
Future Oncol
; 18(11): 1313-1320, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35043682
2.
Current therapy of advanced colorectal cancer according to RAS/RAF mutational status.
Cancer Metastasis Rev
; 39(4): 1143-1157, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32648137
3.
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer.
Oncologist
; 26(3): e414-e424, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33274542
4.
Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe.
Oncologist
; 24(1): e30-e37, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30181313
5.
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial.
J Hepatol
; 69(2): 353-358, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29704513
6.
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 389(10064): 56-66, 2017 01 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27932229
7.
Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW.
J Gastroenterol Hepatol
; 33(4): 814-824, 2018 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28960444
8.
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
Lancet Oncol
; 18(5): 640-653, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28343975
9.
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
Lancet
; 387(10018): 545-557, 2016 Feb 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26615328
10.
[Role of immunotherapy in the management of colorectal cancer]. / Az immunterápia szerepe a vastagbélrák kezelésében.
Magy Onkol
; 61(2): 147-151, 2017 Jun 06.
Artigo
Húngaro
| MEDLINE | ID: mdl-28585616
11.
Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement.
Oncologist
; 21(10): 1183-1190, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27401890
12.
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.
N Engl J Med
; 369(11): 1023-34, 2013 Sep 12.
Artigo
Inglês
| MEDLINE | ID: mdl-24024839
13.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Lancet Oncol
; 16(5): 499-508, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25877855
14.
Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study.
Future Oncol
; 11(18): 2553-62, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26158398
15.
[Occurrence, intratumoral heterogeneity, prognostic and predictive potential of microsatellite instability following surgical resection of primary colorectal carcinomas and corresponding liver metastases]. / Mikroszatellita-instabilitás elofordulása, intratumoralis heterogenitása, prognosztikus és prediktív potenciálja primer colorectalis carcinomák és párosított májáttéteik sebészi kezelését követoen.
Orv Hetil
; 156(36): 1460-71, 2015 Sep 06.
Artigo
Húngaro
| MEDLINE | ID: mdl-26320600
16.
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
Lancet Oncol
; 15(11): 1224-35, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25240821
17.
[Experience with everolimus therapy for patients with metastatic renal cancer in Hungary]. / Áttétes vesedaganatos betegek everolimusterápiájával szerzett hazai tapasztalatok.
Magy Onkol
; 58(1): 4-9, 2014 Mar.
Artigo
Húngaro
| MEDLINE | ID: mdl-24712001
18.
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.
Lancet Oncol
; 14(6): 490-9, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23594786
19.
[First Hungarian experience with pazopanib therapy for patients with metastatic renal cancer]. / Áttétes vesedaganatos betegek pazopanibterápiájával szerzett elsõ hazai tapasztalatok.
Magy Onkol
; 57(3): 173-6, 2013 Sep.
Artigo
Húngaro
| MEDLINE | ID: mdl-24107823
20.
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
Lancet Oncol
; 13(12): 1225-33, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23168362